Pages that link to "Q39375347"

The following pages link to β₂ long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD. (Q39375347):

Displaying 21 items.

• Long-acting beta 2 -agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease (Q24194044) (← links)
• The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease (Q26864937) (← links)
• Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? (Q28391808) (← links)
• Formoterol is more effective than salmeterol in suppressing neutrophil reactivity (Q28596768) (← links)
• The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation. (Q35865433) (← links)
• New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol (Q38154255) (← links)
• Olodaterol: first global approval (Q38155451) (← links)
• Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease (Q38241442) (← links)
• Molecular pathogenesis of cigarette smoking-induced stable COPD. (Q38339473) (← links)
• Bronchodilators, receptors and cross-talk: Together is better? (Q38570698) (← links)
• Olodaterol tiotropium bromide for the treatment of chronic obstructive pulmonary disease. (Q38570714) (← links)
• Tiotropium/Olodaterol: A Review in COPD. (Q38673383) (← links)
• Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update (Q38754002) (← links)
• Chronic inflammatory airway diseases: the central role of the epithelium revisited (Q38791607) (← links)
• Bifunctional Drugs for the Treatment of Respiratory Diseases (Q38992596) (← links)
• How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease? (Q39030602) (← links)
• Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and Its Potential for Therapy as a Target. (Q47650425) (← links)
• Olodaterol tiotropium bromide for the treatment of COPD. (Q51545895) (← links)
• Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study (Q58381887) (← links)
• The Airways' Mechanical Stress in Lung Disease: Implications for COPD Pathophysiology and Treatment Evaluation (Q90469611) (← links)
• Long‐acting beta‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary disease (Q94355405) (← links)